Interferon-induced ISG15 pathway: An ongoing virus-host battle

Trends in Microbiology

Volumn 21, Issue 4, 2013, Pages 181-186

  Zhao, Chen ^a   Collins, Mark N ^a   Hsiang, Tien Ying ^a   Krug, Robert M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Influenza B virus; Interferon; ISG15; NS1B protein; Ovarian tumor domain; Species specificity

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; NONSTRUCTURAL PROTEIN 1; NONSTRUCTURAL PROTEIN 2; PROTEIN E3; PROTEIN ISG15; PROTEIN L; PROTEIN OTU; RETINOIC ACID INDUCIBLE PROTEIN I; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTERIVIRUS; CARBOXY TERMINAL SEQUENCE; CONJUGATION; CRYSTAL STRUCTURE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EQUINE VIRAL ARTERITIS VIRUS; GENETIC CONSERVATION; GENETIC VARIABILITY; HEPATITIS C VIRUS; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NAIRO VIRUS; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SARS CORONAVIRUS; SINDBIS VIRUS; SPECIES DIFFERENCE; STRUCTURE ANALYSIS; TRANSCRIPTION INITIATION; UBIQUITINATION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE; WART VIRUS;

AMINO ACID SEQUENCE; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA B VIRUS; INTERFERONS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; UBIQUITINS;

INFLUENZA B VIRUS; PRIMATES;

EID: 84875854073     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.01.005     Document Type: Review

References (57)

1. Biron C.A., Sen G.C. Interferons and other cytokines. Fields Virology 2001, 321-351. Lippincott Williams & Wilkins. 4th edn. D.M. Knipe (Ed.).
2. Loeb K.R., Haas A.L. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 1992, 267:7806-7813.
3. Haas A.L., et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J. Biol. Chem. 1987, 262:11315-11323.
4. Pattyn E., et al. HyperISGylation of Old World monkey ISG15 in human cells. PLoS ONE 2008, 3:e2427.
5. Zhang D., Zhang D.E. Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 2011, 31:119-130.
6. Yuan W., Krug R.M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 2001, 20:362-371.
7. Zhao C., et al. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:7578-7582.
8. Kim K.I., et al. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Mol. Cell. Biol. 2004, 24:9592-9600.
9. Dastur A., et al. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 2006, 281:4334-4338.
10. Wong J.J., et al. HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10735-10740.
11. Malakhov M.P., et al. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 2002, 277:9976-9981.
12. Oudshoorn D., et al. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS ONE 2012, 7:e29870.
13. Ketscher L., et al. mHERC6 is the essential ISG15 E3 ligase in the murine system. Biochem. Biophys. Res. Commun. 2012, 417:135-140.
14. Lenschow D.J., et al. IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:1371-1376.
15. Hsiang T.Y., et al. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J. Virol. 2009, 83:5971-5977.
16. Lai C., et al. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J. Virol. 2009, 83:1147-1151.
17. Zhao C., et al. ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2253-2258.
18. Giannakopoulos N.V., et al. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. J. Virol. 2009, 83:1602-1610.
19. Okumura A., et al. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1440-1445.
20. Pincetic A., et al. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 2010, 84:4725-4736.
21. Knobeloch K.P., et al. Reexamination of the role of ubiquitin-like modifier ISG15 in the phenotype of UBP43-deficient mice. Mol. Cell. Biol. 2005, 25:11030-11034.
22. Osiak A., et al. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 2005, 25:6338-6345.
23. Werneke S.W., et al. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 2011, 7:e1002322.
24. Malakhova O.A., Zhang D.E. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 2008, 283:8783-8787.
25. Okumura A., et al. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3974-3979.
26. Zhao C., et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:10200-10205.
27. Lu G., et al. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell. Mol. Biol. (Noisy-le-grand) 2006, 52:29-41.
28. Shi H.X., et al. Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification. Mol. Cell. Biol. 2010, 30:2424-2436.
29. Arimoto K., et al. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol. Immunol. 2008, 45:1078-1084.
30. Kim M.J., et al. Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J. Virol. 2008, 82:1474-1483.
31. Tang Y., et al. Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J. Immunol. 2010, 184:5777-5790.
32. Hale B.G., et al. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 2008, 89:2359-2376.
33. Melen K., et al. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J. Virol. 2007, 81:5995-6006.
34. Wang W., et al. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 1999, 5:195-205.
35. Kuo R.L., et al. Influenza A virus strains that circulate in humans differ in the ability of their NS1 proteins to block the activation of IRF3 and interferon-beta transcription. Virology 2010, 408:146-158.
36. Ayllon J., et al. Strain-specific contribution of NS1-activated phosphoinositide 3-kinase signaling to influenza A virus replication and virulence. J. Virol. 2012, 86:5366-5370.
37. Kim M.J., Yoo J.Y. Inhibition of hepatitis C virus replication by IFN-mediated ISGylation of HCV-NS5A. J. Immunol. 2010, 185:4311-4318.
38. Durfee L.A., et al. The ISG15 conjugation system broadly targets newly synthesized proteins: implications for the antiviral function of ISG15. Mol. Cell 2010, 38:722-732.
39. Aramini J.M., et al. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions. J. Biol. Chem. 2011, 286:26050-26060.
40. Kerry P.S., et al. A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS ONE 2011, 6:e17946.
41. Guerra S., et al. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 2008, 4:e1000096.
42. Shors T., Jacobs B.L. Complementation of deletion of the vaccinia virus E3L gene by the Escherichia coli RNase III gene. Virology 1997, 227:77-87.
43. Frias-Staheli N., et al. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007, 2:404-416.
44. Komander D. Mechanism, specificity and structure of the deubiquitinases. Subcell. Biochem. 2010, 54:69-87.
45. James T.W., et al. Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2222-2227.
46. Akutsu M., et al. Molecular basis for ubiquitin and ISG15 cross-reactivity in viral ovarian tumor domains. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2228-2233.
47. Capodagli G.C., et al. Structural analysis of a viral ovarian tumor domain protease from the Crimean-Congo hemorrhagic fever virus in complex with covalently bonded ubiquitin. J. Virol. 2011, 85:3621-3630.
48. Lindner H.A., et al. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 2005, 79:15199-15208.
49. Lindner H.A., et al. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch. Biochem. Biophys. 2007, 466:8-14.
50. Clementz M.A., et al. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 2010, 84:4619-4629.
51. Yin C., et al. Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J. Biol. Chem. 2007, 282:20584-20592.
52. Versteeg G.A., et al. Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. J. Virol. 2010, 84:5423-5430.
53. Chang Y.G., et al. Different roles for two ubiquitin-like domains of ISG15 in protein modification. J. Biol. Chem. 2008, 283:13370-13377.
54. Sridharan H., et al. Species specificity of the NS1 protein of influenza B virus: NS1 binds only human and non-human primate ubiquitin-like ISG15 proteins. J. Biol. Chem. 2010, 285:7852-7856.
55. Guan R., et al. Structural basis for the sequence-specific recognition of human ISG15 by the NS1 protein of influenza B virus. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:13468-13473.
56. Li L., et al. Crystal structure of human ISG15 protein in complex with influenza B virus NS1B. J. Biol. Chem. 2011, 286:30258-30262.
57. Durfee L.A., et al. The basis for selective E1-E2 interactions in the ISG15 conjugation system. J. Biol. Chem. 2008, 283:23895-23902.